Novel therapeutic approaches in inflammatory bowel diseases

Atreya R, Neurath M (2016)

Publication Type: Journal article

Publication year: 2016

Journal

Deutsche Medizinische Wochenschrift Georg Thieme Verlag

Book Volume: 141

Pages Range: 1789-1792

Journal Issue: 24

DOI: 10.1055/s-0042-117625

Abstract

Increasing knowledge regarding the immunopathogenesis of IBD has led to the development or approval of novel therapeutic agents for the treatment of Crohn's disease or ulcerative colitis. The new substances for example include antibodies against IL-12 / 23, anti-adhesion molecules and antisense oligonucleotides. The increase of therapeutic options will lead to a change of currently used therapeutic algorithms. Biomarkers to ensure a more individualized therapeutic approach are urgently needed to improve an efficient therapy of IBD patients.

Authors with CRIS profile

Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur) Markus Neurath Lehrstuhl für Innere Medizin I

How to cite

APA:

Atreya, R., & Neurath, M. (2016). Novel therapeutic approaches in inflammatory bowel diseases. Deutsche Medizinische Wochenschrift, 141(24), 1789-1792. https://doi.org/10.1055/s-0042-117625

MLA:

Atreya, Raja, and Markus Neurath. "Novel therapeutic approaches in inflammatory bowel diseases." Deutsche Medizinische Wochenschrift 141.24 (2016): 1789-1792.

BibTeX: Download